Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease

We report 3 patients with coronavirus disease who had a decline in respiratory status during their hospital course that responded well to intravenous steroids and interleukin-6 receptor antagonist therapy. These patients later showed development of persistent hypoxia with increased levels of d-dimer levels and were given a diagnosis of pulmonary embolisms.

Errataetall:

CommentIn: Emerg Infect Dis. 2020 Oct;26(10):2522-2533. - PMID 32614766

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:26

Enthalten in:

Emerging infectious diseases - 26(2020), 8 vom: 01. Aug., Seite 1941-1943

Sprache:

Englisch

Beteiligte Personen:

Griffin, Daniel O [VerfasserIn]
Jensen, Alexandra [VerfasserIn]
Khan, Mushmoom [VerfasserIn]
Chin, Jessica [VerfasserIn]
Chin, Kelly [VerfasserIn]
Saad, Jennifer [VerfasserIn]
Parnell, Ryan [VerfasserIn]
Awwad, Christopher [VerfasserIn]
Patel, Darshan [VerfasserIn]

Links:

Volltext

Themen:

5GMR90S4KN
9NDF7JZ4M3
Antibodies, Monoclonal, Humanized
Anticoagulants
Biomarkers
COVID-19
Case Reports
Coronavirus disease
D-dimer
Deep vein thrombosis
Enoxaparin
Fibrin Fibrinogen Degradation Products
Fibrin fragment D
Hypercoagulability
I031V2H011
Journal Article
Methylprednisolone Hemisuccinate
Prophylaxis
Pulmonary embolism
Respiratory infections
Rivaroxaban
SARS-CoV-2
Sequelae
Severe acute respiratory syndrome coronavirus 2
Thromboembolic
Tocilizumab
Viruses

Anmerkungen:

Date Completed 29.07.2020

Date Revised 10.01.2021

published: Print-Electronic

CommentIn: Emerg Infect Dis. 2020 Oct;26(10):2522-2533. - PMID 32614766

Citation Status MEDLINE

doi:

10.3201/eid2608.201477

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM309320887